Risk factors for candidemia-related mortality at a medical center in central Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 2, 2006, Pages 155-161

  Cheng, Yu Ren ^a   Lin, Li Chen ^a   Young, Tzuu Guang ^a   Liu, Chun Eng ^a   Chen, Chang Hua ^a   Tsay, Ren Wen ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Antifungal agents; Candida; Fungemia; Microbial sensitivity tests; Risk factors

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; CANDIDA ALBICANS; CANDIDA TROPICALIS; CANDIDIASIS; CENTRAL VENOUS CATHETERIZATION; FEMALE; FUNGEMIA; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; SHOCK; TAIWAN; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; APACHE; CANDIDA; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DIABETES COMPLICATIONS; FEMALE; FLUCONAZOLE; FUNGEMIA; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK; STATISTICS; TAIWAN;

EID: 33745468842     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511.
2. Beck-Sague CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993;167:1247-51.
3. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15: 414-21.
4. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RR Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29:239-44.
5. Hsueh PR, Chen ML, Sun CC, Chen WH, Pan HJ, Yang LS, et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis 2002;8:63-8.
6. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000;44:747-51.
7. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39:1-8.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
9. Alonso-Valle H, Acha O, García-Palomo JD, Farinas-Álvarez C, Fernández-Mazarrasa C, Farinas MC. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003;22: 254-7.
10. Viudes A, Pemán J, Cantón E, Úbeda P, López-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002;21:767-74.
11. Charles PE, Doise JM, Quenot JP, Aube H, Dalle F, Chavanet P, et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 2003;29:2162-9.
12. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed. NCCLS document M27-A2. Wayne, PA. National Committee for Clinical Laboratory Standards; 2002.
13. Clancy CJ, Nguyen MH. Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of Candidemia. Antimicrob Agents Chemother 1999;43: 1289-90.
14. Peyron F, Favel A, Michel-Nguyen A, Gilly M, Regli P, Bolmstrom A. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest. J Clin Microbiol 2001; 39:339-42.
15. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001;14:643-58.
16. Wu SP, Hwang SH, Hwang KP, Lu PL, Tsai JJ, Lee YW, et al. An analysis of nosocomial candidemia among hospitalized adult patients. Nosocom Infect Control J 2002;12:355-65.
17. Wang JL, Chang SH, Hsueh PR, Chen YC. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002. J. Microbiol Immunol Infect 2004;37: 236-41.
18. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001;39: 3254-9.
19. Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, AbiSaid D, et al. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 2000;160:2659-64.
20. Yang YL, Li SY, Cheng HH, Lo HJ; TSARY Hospitals. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis 2005;51: 179-83.
21. Chryssanthou E. Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre Yeast One Colorimetric Antifungal Panel with the NCCLS M27-A reference method. J Clin Microbiol 2001;39:4181-3.
22. Lu JJ, Lee SY, Chiueh TS. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method. J Microbiol Immunol Infect 2004;37:335-42.
23. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989;149:2349-53.
24. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999;29: 253-8.
25. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 1993;218:111-9.
26. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-8.
27. Tran LT, Auger P, Marchand R, Carrier M, Pelletier C. Epidemiological study of Candida species colonization in cardiovascular surgical patients. Mycoses 1997;40:169-73.
28. Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 1996;95:19-28.
29. Nguyen MH, Peacock JE Jr, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995;155:2429-35.